您要查找的是不是：
- Blomme I, Brynger H.Malignant disease in renal transplant patient[J]. 刘龙，黎鉴泉，牛技平.;肾移植术后并发恶性肿瘤6例报告[J]
- At high magnification, the lymphocytes and plasma cells are seen around a renal tubule in a renal transplant patient with acute cellular rejection. 高倍镜可见发生急性细胞排斥反应的肾移植病人的淋巴细胞和浆细胞浸润于肾小管周围。
- We present a clinical report of chylous ascites in a renal transplant patient under sirolimus therapy; our investigation pointed to sirolimus as the cause. 我们报道使用西罗莫司的一例肾移植患者发生乳糜性腹水，我们的研究提示西罗莫司的使用是其产生的原因。
- In our transplant center, we used an immunosuppression reduction regimen in stable renal transplant patients. 在本移植中心，我们对稳定的肾移植患者采用降低剂量的免疫抑制方案。
- Rresults.It is safe,effective,and reasonable for renal transplant patients to use cyclosporine A by pharmaceutical care. 结果通过药学监护,使肾移植患者使用环孢素A安全、有效和合理。
- OBJECTIVE To study the reasons and treatments of cytomegalovirus(CMV) infection complicated with ARDS in renal transplant patients. 目的探索肾移植患者巨细胞病毒(CMV)感染的诱因和治疗措施。
- Abstract：Immunosuppression for immunologically high-risk renal transplant patients usually inoles antithymocyte globulin induction with triple drug maintenance therapy. 摘要:肾移植免疫高危患者的免疫抑制方案通常是予抗胸腺细胞球蛋白诱导免疫抑制;然后以三联免疫抑制药物维持治疗.
- Gema F F,Rafael E,Emilio R,et al.The risk of cardiovascular disease associated with proteinuria in renal transplant patients [J].Transplantation,2002,73 (8):1345. 任吉忠;闵志廉;朱有华;等.;肾移植患者合并严重肺部感染的临床诊断与救治[J]
- CONCLUSION: The presence of HLA antibodies does not preclude the successful reduction of immunosuppression in renal transplant patients with stable graft function. 结论：对肾移植术后移植物功能稳定的患者来说，HLA抗体的存在并不会阻碍降低剂量免疫抑制方案的疗效。
- In 590 cadaveric renal transplant patients, acute rejection rate was 23. 2% and chronic 17.1%, and the rate of 1 and 3 year-suvival was 86. 9% and 69. 2% respectively. 590例尸体肾移植中;急性排斥反应的发生率为22.;7%25;慢性排斥反应的发生率为17
- METHODS The whole blood concentration of FK506 on 206 renal transplant patients was determined by microparticle eniyme immuno assay, the results and the therapeutic effect were studied. 方法:采用微粒子酶免分析法对206例肾移植患者进行血药浓度监测,并对其结果及疗效进行分析总结。
- Lebranchu Y et al. Immunoprophylaxis with basiliximab with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. Am J Transplantat 2002;2:48-56. 对于不同类型的肾移植患者，舒莱联合新山地明为基本用药的免疫方案中，也显示出其明显的优势。
- Methods ELISA was used to detect FK506 valley point in 27 renal transplant patients at different postoperative periods.Based on the results combined with clinical findings,the dosages were adjusted. 方法采用酶联免疫吸附法(ELISA)对27例肾移植术后患者不同时期全血中FK506谷值浓度进行监测,并结合临床调整剂量,分析该法准确性及对临床FK506应用的指导作用。
- Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline data. 氟伐他汀对肾脏移植患者心脏事件的影响:ALERT(评估来适可在肾脏移植中的作用)研究设计及基线资料。
- ABST?RACT:OBJECTIVE To develop an HPLC/ESI + MS method for quantifying cyclosporine A (CsA)in the whole blood of renal transplantation patients. 目的 :建立液相色谱 -电喷雾质谱联用 (HPLC/ESI+ MS)测定器官移植患者全血中环孢素A(CsA)方法。
- Conclusions To renal transplantation patients,the both influences of biologic factors and psychological factors should be emph... 结论对肾移植病人,不仅要重视生物因素的影响,也应重视社会心理因素对患者的影响。
- Objective:To investigate the feasibility of cholangiolithasis surgery of hemodlalysis and renal transplantation patients. 目的:探讨血液透析及肾移植患者的胆道结石手术的可行性。
- The frequencies distribution of Fok I, Aap I, Bsm I and Taq I alleles in 80 renal transplantation patients in Shanghai all in accordance with the Hardy-Weinberg equilibrium. 80例上海移植肾受者VDR基因四个多态位点中仅ApaI酶切位点的不同基因型间腰椎和股骨粗隆部位BMD有明显差异（p<0.;05）；
- This study investigated the application protocol of immunosuppressive agents during the treatment of pulmonary infection in renal transplantation patients. 文章旨在探讨肾移植术后肺部感染患者免疫抑制剂的应用方案。
- Isolation of Malassezia furfur from the Groin Abscess of a Renal Transplant Patient 肾移植患者皮肤脓肿分离出糠秕马拉色菌1例报道
